Lin YB - Search Results

1

Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis.

Zhai WY, Zhao ZR, Chen S, Yu H, Lin YB, Wang YZ, Long H. Zhai WY, et al. Among authors: lin yb. J Immunother Cancer. 2022 Sep;10(9):e005160. doi: 10.1136/jitc-2022-005160. J Immunother Cancer. 2022. PMID: 36109085 Free PMC article.

2

Immunological markers predict the prognosis of patients with squamous non-small cell lung cancer.

Jiang L, Zhao Z, Jiang S, Lin Y, Yang H, Xie Z, Lin Y, Long H. Jiang L, et al. Immunol Res. 2015 Jul;62(3):316-24. doi: 10.1007/s12026-015-8662-0. Immunol Res. 2015. PMID: 25999209

3

Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer.

Jiang L, Jiang S, Lin Y, Yang H, Zhao Z, Xie Z, Lin Y, Long H. Jiang L, et al. Oncotarget. 2015 Sep 8;6(26):22072-80. doi: 10.18632/oncotarget.4299. Oncotarget. 2015. PMID: 26061746 Free PMC article.

4

Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer.

Jiang L, Jiang S, Lin Y, Yang H, Xie Z, Lin Y, Long H. Jiang L, et al. Medicine (Baltimore). 2015 Nov;94(46):e2054. doi: 10.1097/MD.0000000000002054. Medicine (Baltimore). 2015. PMID: 26579815 Free PMC article.

5

Modified inflammation-based score as an independent malignant predictor in patients with pulmonary focal ground-glass opacity: a propensity score matching analysis.

Jiang L, Jiang S, Lin Y, Yang H, Zhao Z, Xie Z, Lin Y, Long H. Jiang L, et al. Sci Rep. 2016 Jan 11;6:19105. doi: 10.1038/srep19105. Sci Rep. 2016. PMID: 26752624 Free PMC article.

6

Prognostic Effect of TP53 and PKD Co-Mutations in Patients with Resected Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma.

Liu DH, Zhao ZR, Lin YB, Zhou WJ, Hou JY, Ye ZH, Long H. Liu DH, et al. Among authors: lin yb. Ann Surg Oncol. 2019 Jun;26(6):1934-1941. doi: 10.1245/s10434-019-07254-6. Epub 2019 Feb 28. Ann Surg Oncol. 2019. PMID: 30820786

7

Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing.

Zhao ZR, Lin YB, Ng CSH, Zhang R, Wu X, Ou Q, Chen W, Zhou WJ, Lin YB, Su XD, Shao YW, Long H. Zhao ZR, et al. Among authors: lin yb. Oncologist. 2019 Oct;24(10):1368-1374. doi: 10.1634/theoncologist.2018-0567. Epub 2019 Mar 14. Oncologist. 2019. PMID: 30872465 Free PMC article.

8

Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.

Fu X, Wang F, Su X, Luo G, Lin P, Rong T, Xu G, Zhang R, Wang X, Lin Y, Fu J, Zhang X. Fu X, et al. Ann Surg Oncol. 2021 Jul;28(7):3930-3938. doi: 10.1245/s10434-020-09241-8. Epub 2020 Nov 28. Ann Surg Oncol. 2021. PMID: 33249523

9

Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.

Zhao ZR, Yang CP, Chen S, Yu H, Lin YB, Lin YB, Qi H, Jin JT, Lian SS, Wang YZ, You JQ, Zhai WY, Long H. Zhao ZR, et al. Among authors: lin yb. Oncoimmunology. 2021 Oct 25;10(1):1996000. doi: 10.1080/2162402X.2021.1996000. eCollection 2021. Oncoimmunology. 2021. PMID: 34712513 Free PMC article. Clinical Trial.

10

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.

Zhai WY, Duan FF, Chen S, Wang JY, Lin YB, Wang YZ, Rao BY, Zhao ZR, Long H. Zhai WY, et al. Among authors: lin yb. Front Genet. 2022 Jan 5;12:798131. doi: 10.3389/fgene.2021.798131. eCollection 2021. Front Genet. 2022. PMID: 35069695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters